Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract To the Editor.—We read with great interest two adjacent articles in the December 1976 issue of the Archives by Becker and Shin (94:2057-2058) and by Shin and co-workers (94:2059-2060). These articles suggest that epinephrine hydrochloride responsiveness correlates with the occurrence of field loss in people with elevated intraocular pressure levels. This observation is important in trying to understand the pathogenic mechanism and the clinical manifestations in glaucoma. However, we would like to urge caution in using "epinephrine responsiveness" as an indication for therapy in individuals with abnormal pressure, at least until further evidence is available. In a report by Becker and Morton (Am J Ophthalmol 62:272-277, 1966), 50 subjects were treated with epinephrine to one eye and followedup prospectively for four to five years. Of the seven individuals in whom visual field loss developed, only two were "epinephrine responders" by the criterion used in the recent article by Becker
Archives of Ophthalmology – American Medical Association
Published: May 1, 1977
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.